Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preclinical feasibility study of liver antigen-specific TCR-engineered T cells for recurrent hepatocellular carcinoma after liver transplantation
NL-OMON47991Completed
- Sponsor
- Erasmus MC
- Start
- Dec 2019
- Countries
- 1
01
Overview
Open-label, single-arm trial in hepatocellular carcinoma (HCC), sponsored by Erasmus MC. Started Dec 2019; status: completed.
02
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NL-OMON47991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47991.